J&J-backed Locus closes $35M financing to push CRISPR-based antibacterial drug into phase 2/3news2022-05-18T19:08:12+00:00May 18th, 2022|FierceBiotech|
Applied Molecular Transport’s co-founder exits along with 40% of staff as early pipeline activity pausednews2022-05-18T15:11:00+00:00May 18th, 2022|FierceBiotech|
‘We just don’t have the studies’: New report details critical diversity shortcomings in US clinical researchnews2022-05-18T14:08:57+00:00May 18th, 2022|FierceBiotech|
Flagship Pioneering unfurls cell signaling company Sonata Therapeuticsnews2022-05-18T13:39:25+00:00May 18th, 2022|FierceBiotech|
Barber buzzes into Aquestive CEO post as Kendall leaves amid FDA delaynews2022-05-18T12:36:20+00:00May 18th, 2022|FierceBiotech|
With lead gene therapy nearing the clinic, SwanBio leans heavily on Syncona to close $56M series Bnews2022-05-18T11:30:16+00:00May 18th, 2022|FierceBiotech|
Pfizer, Sarepta team with fellow DMD gene therapy makers to get to the bottom of adverse eventsnews2022-05-17T19:06:06+00:00May 17th, 2022|FierceBiotech|
UPDATE: Pfizer, Sarepta team with fellow DMD gene therapy makers to get to the bottom of adverse eventsnews2022-05-17T19:06:06+00:00May 17th, 2022|FierceBiotech|
FDA has change of heart, plans to convene advisory meeting for Cytokinetics’ cardiac mednews2022-05-17T14:35:13+00:00May 17th, 2022|FierceBiotech|
Ampio’s years of troubles come to a head with internal investigation, trio of COVID trial failuresnews2022-05-17T13:18:54+00:00May 17th, 2022|FierceBiotech|
